MRA Convenes Top Melanoma Researchers at Fourth Annual Scientific Retreat
retreat 2012

MRA convened its Fourth Annual Scientific Retreat in Washington, DC, March 1-2, 2012. The retreat brought together nearly 200 leading scientists and clinicians from around the world, as well as senior leadership from nonprofit foundations, corporate allies, government agencies, industry, and other key stakeholders to share early findings, identify future directions, discuss ideas, and look for synergies and partnerships (view the agenda).

Highlights from this year's tremendously successful Scientific Retreat included MRA's first Young Investigator's Breakfast which featured a discussion led by Mike Milken engaging Young Investigator Award recipients, mentors, donors, and industry partners. The discussion sparked several attendees (individuals and industry representatives) to explore making gifts to support the program. Another highlight was the unveiling of the new MRA Video, Accelerating Progess: Moving Toward a Cure for Melanoma, produced for MRA pro bono by Birds Nest Foundation. The video is now available here

As we have done in past years, MRA produced a summary report for wide public distribution on the highlights and key themes from this year's retreat.

MRA is grateful to its corporate allies for their generous financial and in-kind support of the retreat, including: Bristol-Myers Squibb Company, Celgene Corporation, Genentech, Lilly, Amgen, Life Technologies, National Pharmaceutical Council, Spa Finder, Aduro Biotech, AdvaMedDx, Bio Biotechnology Industry Organization, Caris Life Sciences, Celldex Therapeutics, Centers for Therapeutic Innovation, Illumina, Provectus Pharmaceuticals Inc., and the Hazen Polsky Foundation.

View the agenda.